Raman spectroscopy is a widely developing approach for noninvasive analysis that can provide information on chemical composition and molecular structure. High chemical specificity calls for developing different medical diagnostic applications based on Raman spectroscopy. This review focuses on the Raman-based techniques used in medical diagnostics and provides an overview of such techniques, possible areas of their application, and current limitations. We have reviewed recent studies proposing conventional Raman spectroscopy and surface-enhanced Raman spectroscopy for rapid measuring of specific biomarkers of such diseases as cardiovascular disease, cancer, neurogenerative disease, and coronavirus disease (COVID-19). As a result, we have discovered several most promising Raman-based applications to identify affected persons by detecting some significant spectral features. We have analyzed these approaches in terms of their potentially diagnostic power and highlighted the remaining challenges and limitations preventing their translation into clinical settings.
The differentiation of skin melanomas and basal cell carcinomas (BCCs) was demonstrated based on combined analysis of Raman and autofluorescence spectra stimulated by visible and NIR lasers. It was ex vivo tested on 39 melanomas and 40 BCCs. Six spectroscopic criteria utilizing information about alteration of melanin, porphyrins, flavins, lipids, and collagen content in tumor with a comparison to healthy skin were proposed. The measured correlation between the proposed criteria makes it possible to define weakly correlated criteria groups for discriminant analysis and principal components analysis application. It was shown that the accuracy of cancerous tissues classification reaches 97.3% for a combined 6-criteria multimodal algorithm, while the accuracy determined separately for each modality does not exceed 79%. The combined 6-D method is a rapid and reliable tool for malignant skin detection and classification.
<!-- *** Custom HTML *** --> We demonstrate the applicability of near-infrared (NIR) autofluorescence (AF) of skin tissues to differentiating neoplasms based on performing a series of experiments with in vivo and ex vivo skin tumors and analyzing the skin AF spectral shape, the excitation–emission matrices, and the photobleaching properties of malignant and benign neoplasms. The melanin-pigmented lesions showed an increase of the AF in comparison to nonpigmented tissue fluorescent emission using excitation at 785 nm. Autofluorescent spectral differences can be associated with different concentration of melanocytes cells in the investigated skin lesions. The differences in excitation–emission matrices for tested tissues prove that melanin is the dominant NIR fluorophore in human skin. Further, we found that the photobleaching properties of normal skin and neoplasms differ significantly. The highlighted differences in skin tissue AF response can be used in rapid analysis of large tissue areas and can complement other methods of skin tumor detection.
In the paper, we present test results of methods for the noninvasive diagnosis of skin neoplasms, based on the hyperspectral registration of images by using a camera with an acousto-optic tunable filter. For the identification of oncological pathologies, an integral spectral index has been proposed for a set of concentric regions around the source of neoplasm growth for the tissue sample under study. As well as taking account of changes in the spectral properties of the tissue, the introduced index indirectly takes into account classical ABCD dermatoscopic features: asymmetry, border irregularity, color diversity, and the tumor diameter. Results of training set separating are presented and the applicability of the proposed approaches to the clinical practice is shown.